Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD).

Han SH, Zhou J, Saghayam S, Vanar S, Phanuphak N, Chen YM, Sirisanthana T, Sungkanuparph S, Lee CK, Pujari S, Li PC, Oka S, Saphonn V, Zhang F, Merati TP, Law MG, Choi JY; TREAT Asia HIV Observational Database.

Endocr J. 2011;58(6):475-84. Epub 2011 Apr 27.

2.

Stavudine versus zidovudine and the development of lipodystrophy.

Bogner JR, Vielhauer V, Beckmann RA, Michl G, Wille L, Salzberger B, Goebel FD.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):237-44.

PMID:
11464142
3.

Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.

Bhutia E, Hemal A, Yadav TP, Ramesh KL.

Afr Health Sci. 2014 Jun;14(2):408-13. doi: 10.4314/ahs.v14i2.17.

4.

A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.

[No authors listed]

AIDS Res Hum Retroviruses. 2016 Aug;32(8):772-81. doi: 10.1089/AID.2015.0294. Epub 2016 May 3.

5.

Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.

Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM.

PLoS One. 2016 Mar 2;11(3):e0150512. doi: 10.1371/journal.pone.0150512. eCollection 2016.

6.

The TREAT Asia HIV Observational Database: baseline and retrospective data.

Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG; TREAT Asia HIV Observational Database.

J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):174-9.

7.

Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Aurpibul L, Puthanakit T, Taejaroenkul S, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2012 Apr;31(4):384-8. doi: 10.1097/INF.0b013e31823f0e11.

PMID:
22124211
8.
9.

Lipodystrophy and reversal of facial lipoatrophy in perinatally HIV-infected children and adolescents after discontinuation of stavudine.

Sawawiboon N, Wittawatmongkol O, Phongsamart W, Prasitsuebsai W, Lapphra K, Chokephaibulkit K.

Int J STD AIDS. 2012 Jul;23(7):497-501. doi: 10.1258/ijsa.2011.011348.

PMID:
22844004
10.

Prevalence of and clinical factors associated with lipoatrophy in HIV-infected Koreans receiving highly active antiretroviral therapy.

Han SH, Chin BS, Choi HK, Shin SY, Chae YT, Baek JH, Kim CO, Choi JY, Song YG, Lee HC, Kim JM.

Tohoku J Exp Med. 2009 Oct;219(2):145-53.

11.

Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.

Rajesh R, Vidyasagar S, Varma DM, Mohiuddin S, Noorunnisa.

Int J Risk Saf Med. 2011;23(3):171-80. doi: 10.3233/JRS-2011-0531.

PMID:
22020397
13.

Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy.

Kinabo GD, Sprengers M, Msuya LJ, Shayo AM, van Asten H, Dolmans WM, van der Ven AJ, Warris A.

Pediatr Infect Dis J. 2013 Jan;32(1):39-44. doi: 10.1097/INF.0b013e3182755a34.

PMID:
23038217
14.
15.

Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database.

Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG.

HIV Med. 2007 Jan;8(1):8-16.

16.

High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.

van Griensven J, De Naeyer L, Mushi T, Ubarijoro S, Gashumba D, Gazille C, Zachariah R.

Trans R Soc Trop Med Hyg. 2007 Aug;101(8):793-8. Epub 2007 Apr 30.

PMID:
17467756
17.

Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD).

Zhou J, Li PC, Kumarasamy N, Boyd M, Chen YM, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang FJ, Omar SF, Lee CK, Ditangco R, Merati TP, Lim PL, Choi JY, Law MG, Pujari S; TREAT Asia HIV Observational Database.

HIV Med. 2010 Jan;11(1):31-9. doi: 10.1111/j.1468-1293.2009.00738.x. Epub 2009 Jul 6.

18.

Prior antiretroviral therapy experience protects against zidovudine-related anaemia.

Huffam SE, Srasuebkul P, Zhou J, Calmy A, Saphonn V, Kaldor JM, Ditangco R; TREAT Asia HIV Observational Database (TAHOD).

HIV Med. 2007 Oct;8(7):465-71.

19.

Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database.

Boettiger DC, Kerr S, Ditangco R, Merati TP, Pham TT, Chaiwarith R, Kiertiburanakul S, Li CK, Kumarasamy N, Vonthanak S, Lee C, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Sohn A, Law M.

PLoS One. 2014 Sep 3;9(9):e106525. doi: 10.1371/journal.pone.0106525. eCollection 2014.

20.

HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).

Han N, Wright ST, O'Connor CC, Hoy J, Ponnampalavanar S, Grotowski M, Zhao HX, Kamarulzaman A; Australian HIV Observational Database (AHOD); TREAT Asia HIV Observational Database (TAHOD).

HIV Med. 2015 Mar;16(3):152-60. doi: 10.1111/hiv.12188. Epub 2014 Nov 18.

Supplemental Content

Support Center